Atlas of Gross Autopsy Pathology


* Florey HW. The history and scope of pathology. In: Florey L, ed. General pathology . Philadelphia: WB Saunders; 1970:1-21.

External Findings

Figure 16-1, Cachexia.

Figure 16-2, Livor mortis (lividity).

Figure 16-3, Conjunctival pterygia.

Figure 16-4, Visible or palpable masses.

Figure 16-5, Ulnar deviation of phalanges.

Figure 16-6, Abnormalities of pigmentation.

Figure 16-7, Edema.

Figure 16-8, Stasis dermatitis.

Figure 16-9, Lymphedema.

Figure 16-10, Cellulitis.

Figure 16-11, Contusions.

Figure 16-12, Ecchymoses.

Figure 16-13, Petechiae and purpural hemorrhages.

Figure 16-14, Ecthyma gangrenosum.

Figure 16-15, Kaposi sarcoma.

Figure 16-16, Defibrillator marks.

Figure 16-17, Acral necrosis.

Figure 16-18, Abdominal distension.

Figure 16-19, Sacral decubitus ulcer.

Figure 16-20, Evidence of therapeutic interventions.

Pericardial, Pleural, and Peritoneal Cavities

Figure 16-21, Iatrogenic rib fractures.

Figure 16-22, Hemopericardium.

Figure 16-23, Fibrinous pericarditis.

Figure 16-24, Suppurative pericarditis.

Figure 16-25, Hemothorax.

Figure 16-26, Acute serofibrinous pleuritis related to pneumonia.

Figure 16-27, Suppurative pleuritis (empyema).

Figure 16-28, Pleural plaques.

Figure 16-29, Malignant mesothelioma.

Figure 16-30, Metastatic carcinoma involving the pleura.

Figure 16-31, Dilation of the small and large intestines.

Figure 16-32, Hemoperitoneum.

Figure 16-33, Bacterial peritonitis.

Figure 16-34, Peritonitis.

Figure 16-35, Omentum with fat necrosis.

Figure 16-36, Tuberculous peritonitis.

Figure 16-37, Carcinoma metastatic to peritoneum.

Cardiovascular System

Figure 16-38, Dilated cardiomyopathy.

Figure 16-39, Left ventricular hypertrophy.

Figure 16-40, Right ventricular hypertrophy.

Figure 16-41, Epicardial fibrous plaques.

Figure 16-42, Eccentric and concentric hypertrophy.

Figure 16-43, Dilated cardiomyopathy.

Figure 16-44, Right ventricular dilation.

Figure 16-45, Hypertrophic cardiomyopathy.

Figure 16-46, Subaortic stenosis.

Figure 16-47, Myocardial bridge.

Figure 16-48, Coronary artery thrombus.

Figure 16-49, Acute transmural myocardial infarct.

Figure 16-50, Acute subendocardial myocardial infarct.

Figure 16-51, Acute and healed myocardial infarcts.

Figure 16-52, Healed posteroseptal myocardial infarct.

Figure 16-53, Healed transmural and subendocardial myocardial infarcts.

Figure 16-54, Insertion sites for chordae tendineae.

Figure 16-55, Acute and healed subendocardial myocardial infarcts.

Figure 16-56, Large acute subendocardial myocardial infarct.

Figure 16-57, Subendocardial myocardial infarct in papillary muscle.

Figure 16-58, Papillary muscle rupture from acute myocardial infarction.

Figure 16-59, Ventricular aneurysm from myocardial infarction.

Figure 16-60, Ventricular aneurysm from myocardial infarction.

Figure 16-61, Myocarditis.

Figure 16-62, Giant cell myocarditis.

Figure 16-63, Sarcoid myocarditis.

Figure 16-64, Disseminated infection, myocardial.

Figure 16-65, Pericardial metastasis.

Figure 16-66, Amyloid heart.

Figure 16-67, Arrhythmogenic right ventricular cardiomyopathy.

Figure 16-68, Atrial myxoma.

Figure 16-69, Bicuspid aortic valve.

Figure 16-70, Aortic stenosis.

Figure 16-71, Mitral stenosis.

Figure 16-72, Mitral stenosis.

Figure 16-73, Mitral annular calcification.

Figure 16-74, Ring (annular) abscess.

Figure 16-75, Infective endocarditis of a deformed mitral valve.

Figure 16-76, Infective endocarditis of aortic valve.

Figure 16-77, Infective endocarditis of tricuspid valve.

Figure 16-78, Nonbacterial thrombotic endocarditis. Nonbacterial thrombotic endocarditis primarily affects debilitated patients, hence its old categorization as “marantic.” Resembling the lesions of infective endocarditis, these nodules are composed of sterile thrombi. This mitral valve shows a linear array of tiny vegetations (arrows) along the edges of the leaflets, with no evidence of leaflet destruction.

Figure 16-79, Large nonbacterial thrombotic endocarditis.

Figure 16-80, Mitral valve prolapse.

Figure 16-81, Mitral valve prolapse, severe.

Figure 16-82, Mural thrombus.

Figure 16-83, Fatty streaks, aorta.

Figure 16-84, Severe atherosclerosis, aorta.

Figure 16-85, Aortic aneurysm.

Figure 16-86, Dissecting hematoma of aorta.

Figure 16-87, Type A aortic dissection.

Figure 16-88, Thromboembolism to the superior mesenteric artery.

Figure 16-89, Deep venous thrombus.

Figure 16-90, Vena cava filter.

Respiratory System

Figure 16-91, Iatrogenic laryngeal ulcers.

Figure 16-92, Upper respiratory tract bacterial infection.

Figure 16-93, Upper respiratory tract fungal infection.

Figure 16-94, Laryngeal edema.

Figure 16-95, Upper respiratory tract papillomatosis.

Figure 16-96, Squamous cell carcinoma of the larynx.

Figure 16-97, Dorsal lividity in lung.

Figure 16-98, Diffuse alveolar damage (adult respiratory distress syndrome).

Figure 16-99, Pulmonary artery atherosclerosis.

Figure 16-100, Large pulmonary thromboembolus.

Figure 16-101, Focal pulmonary hemorrhage.

Figure 16-102, Acute pulmonary infarct.

Figure 16-103, Healing pulmonary infarct.

Figure 16-104, Centriacinar (centrilobular) emphysema.

Figure 16-105, Centriacinar emphysema.

Figure 16-106, Panacinar emphysema.

Figure 16-107, Emphysematous bullae.

Figure 16-108, Sudden death in a patient with asthma.

Figure 16-109, Bronchiectasis.

Figure 16-110, Aspiration pneumonia.

Figure 16-111, Bacterial lobar pneumonia.

Figure 16-112, Bronchopneumonia.

Figure 16-113, Lung abscess.

Figure 16-114, Viral pneumonias.

Figure 16-115, Tuberculosis.

Figure 16-116, Apical pulmonary fibrosis (cap).

Figure 16-117, Miliary pneumonia.

Figure 16-118, Fungal pneumonia.

Figure 16-119, Pulmonary sarcoidosis.

Figure 16-120, Idiopathic pulmonary fibrosis.

Figure 16-121, Lung carcinoma.

Figure 16-122, Postobstructive pneumonia.

Figure 16-123, Metastatic tumors in lung.

Gastrointestinal System

Figure 16-124, Esophageal diverticula.

Figure 16-125, Gastroesophageal tears.

Figure 16-126, Esophageal varices.

Figure 16-127, Glycogenic acanthosis.

Figure 16-128, Viral esophagitis.

Figure 16-129, Fungal esophagitis.

Figure 16-130, Esophageal leiomyoma.

Figure 16-131, Carcinoma of the esophagus.

Figure 16-132, Barrett esophagus with adenocarcinoma.

Figure 16-133, Postmortem loss of gastric mucosa.

Figure 16-134, Gastric stress ulcers.

Figure 16-135, Gastric candidiasis.

Figure 16-136, Iatrogenic gastric ulceration.

Figure 16-137, Peptic ulcers.

Figure 16-138, Bezoars.

Figure 16-139, Gastric mesenchymal tumors.

Figure 16-140, Gastric carcinoma.

Figure 16-141, Upper gastrointestinal lymphoma.

Figure 16-142, Kaposi sarcoma.

Figure 16-143, Lacteal, small intestine.

Figure 16-144, Meckel diverticulum.

Figure 16-145, Neuroendocrine tumor (NET), small intestine.

Figure 16-146, Enterocolitis.

Figure 16-147, AIDS enteropathy.

Figure 16-148, Crohn disease.

Figure 16-149, Ulcerative colitis.

Figure 16-150, Bowel infarct.

Figure 16-151, Typhlitis.

Figure 16-152, Acquired diverticular disease of the intestines.

Figure 16-153, Diverticulitis.

Figure 16-154, Intussusception.

Figure 16-155, Volvulus.

Figure 16-156, Tumor metastatic to small intestine.

Figure 16-157, Colonic polyps.

Figure 16-158, Carcinoma of the colon.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here